U.S. Senator Bernie Sanders this week urged regulators to allow pharmacies and m...
- U.S. Senator Bernie Sanders this week urged regulators to allow pharmacies and manufacturers to resume distributing unbranded, lower-cost versions of a drug used to treat a rare neuromuscular disorder, according to a letter provided by his office to Reuters.
The drugmaker, in response to a recent query from Sanders, said its prices are in line with similar products in the industry.Before the launch of Firdapse, patients were able to get the same drug for free from Jacobus Pharmaceuticals, a small New Jersey-based drug company, which offered it through an FDA program called “compassionate use.”
FDA spokeswoman Jennifer Rodriguez, in an emailed statement, said the FDA has received the letter and will respond directly to the senator. HHS also said it has received the letter and will respond. “Catalyst may be the most recent company to exploit their monopoly after receiving FDA approval for an inexpensive old drug, but they were certainly not the first,” Sanders said in the letter.
France Dernières Nouvelles, France Actualités
Similar News:Vous pouvez également lire des articles d'actualité similaires à celui-ci que nous avons collectés auprès d'autres sources d'information.
Senator Sanders urges FDA to allow older versions of $375K drugU.S. Senator Bernie Sanders this week urged regulators to allow pharmacies and m...
Lire la suite »
U.S. senators tell drug company executives pricing is 'morally repugnant'U.S. senators called drug pricing practices 'morally repugnant' and to...
Lire la suite »
'Wacky' drug price system keeps costs high for patients paying for prescriptions, FDA Chief saysRebates are a favorite target of pharmaceutical companies, who say pharmaceutical benefit managers extract huge discounts but keep them for themselves instead of sharing the savings with patients.
Lire la suite »
We need more drug price transparency, says Senator Chuck Grassley'I think that there's not enough information available about how prices are arrived at,' Sen. Chuck Grassley said yesterday on drug pricing in the U.S. 'There seems to be a great deal of secrecy.'
Lire la suite »
Drugmakers’ CEOs clash with senators in hearing on drug price hikesExecutives from seven pharmaceutical giants endure grillings but also push back Tuesday on Capitol Hill, as they testify before the Senate Finance Committee about rising drug prices.
Lire la suite »
Senators tell drug company executives pricing is 'morally repugnant'U.S. Senators called drug pricing practices 'morally repugnant' and to...
Lire la suite »